Abattis Bioceuticals Corp. is providing an update as the company moves to a phase of building on recent investments and anticipates significant revenue growth in the fourth quarter of 2018.
Read more
ABATTIS CONTINUES TO BUILD ON RECENT INVESTMENTS WITH PLANS FOR SIGNIFICANT REVENUE GROWTH
